ENG and Alzheimer disease: Our present study evaluated the feasibility of using ENG as a therapeutic target for AD and reported for the first time that specifically decreasing the expression of ENG in BMECs or systemic administration of an ENG antibody Carotuximab can improve cognitive dysfunction caused by vascular injuries.